Precision BioSciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | +22.6% | +35.6% | +94.4% | +10.6% | -1.3% | -9.7% | +34.1% | +7.3% | -84.6% | +583.0% | +20.1% | +84.8% | +320.9% | -65.1% | -73.6% | -47.7% | +15.2% | +92.7% | +43.9% | -17.2% | +125.4% | -33.7% | -46.4% | +149.8% | +183.8% | -98.8% | +10.8% | -95.5% | -37.9% | -27.8% | +263,007.7% | -68.3% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.3% | +0.9% | +1.2% | +0.1% | +4.7% | -14.6% | -23.6% | -8.3% | -3.2% | -26.8% | -25.1% | – | – | -3.2% | +0.6% | – | – | – | |
| – | +0.3% | +22.6% | +35.6% | +94.4% | +10.6% | -1.3% | -9.7% | +34.1% | +7.3% | -84.6% | +583.0% | +20.1% | +84.8% | +320.9% | -65.1% | -73.6% | -83.3% | +50.2% | +221.0% | +62.7% | -21.9% | +167.7% | -36.3% | -36.5% | +149.8% | +183.8% | -98.8% | +10.8% | -95.5% | -37.9% | -27.8% | +263,007.7% | -68.3% | – | – | |
| – | +19.8% | +33.9% | -10.4% | +68.4% | +21.7% | +14.0% | -13.0% | +0.6% | +25.0% | +1.2% | -1.2% | -7.0% | +10.7% | +45.5% | -30.3% | +2.0% | -30.8% | +16.3% | -49.7% | +9.1% | -14.6% | +21.1% | +22.7% | -9.8% | -0.3% | +29.1% | -24.0% | +21.6% | -14.6% | -6.0% | +4.6% | +8.3% | -9.4% | -5.5% | – | |
| – | +17.8% | +18.3% | +3.9% | +42.9% | +7.5% | +30.1% | +8.5% | +20.2% | +13.4% | -9.5% | -1.9% | +7.8% | +3.2% | +4.6% | -3.0% | +10.2% | +0.7% | -1.9% | -1.4% | -2.5% | +10.1% | -11.3% | -2.0% | -11.4% | -1.3% | +1.2% | +2.8% | +9.2% | -10.7% | +6.7% | -19.7% | -1.3% | -5.9% | -0.5% | – | |
| – | +19.3% | +30.1% | -7.2% | +62.0% | +18.6% | +17.2% | -8.3% | +5.7% | +21.5% | -1.8% | -1.4% | -3.2% | +8.6% | +34.4% | -24.6% | +4.2% | -23.4% | +9.8% | -36.6% | +3.2% | -2.8% | +3.4% | +14.2% | -6.5% | -0.7% | +18.3% | -15.1% | +16.6% | -13.1% | -1.1% | -5.5% | +4.9% | -8.2% | -3.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -153.4% | – | – | – | – | – | – | – | – | – | – | – | -188.1% | – | – | – | – | – | -172.6% | – | – | |
| – | +0.0% | +0.0% | – | – | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | +129.2% | -3.6% | -20.8% | +323.8% | +127.5% | +20.0% | +7.4% | +5.9% | +4.2% | +0.5% | -0.9% | -2.4% | -54.3% | +53.1% | -9.7% | +1.1% | +1.1% | -3.9% | -10.6% | -3.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.1% | – | – | – | – | – | – | – | – | – | – | +281.3% | -150.2% | – | – | – | – | – | -195.8% | – | – | |
| – | – | +34.1% | +131.1% | -275.5% | – | – | -58.1% | -23.5% | -30.2% | -83.8% | -73.8% | -3.6% | – | – | +14.6% | -3.6% | +1,450.9% | +74.5% | -29.1% | +687.3% | -118.8% | – | – | – | -51.5% | -199.9% | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.1% | – | – | – | – | – | – | – | – | – | – | +281.3% | -150.2% | – | – | – | – | – | -191.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -135.5% | – | – | – | – | – | – | – | – | – | – | +227.6% | -143.7% | – | – | – | – | – | -186.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.